Skip to main content

Table 2 Comparison of observation indexes at baseline and 6 month follow-up between the major BRVO and macular BRVO

From: Efficacy of intravitreal Lucentis injection on major and macular branch retinal vein occlusion

 

Major BRVO(n = 22)

Macula BRVO(n = 14)

t

p

BCVA (logMAR)

baseline

0.60 ± 0.11

0.59 ± 0.13

0.25

0.81

6 month

0.28 ± 0.11

0.21 ± 0.08

2.06

0.047

t

9.65

9.31

  

p

< 0.001

< 0.001

  

CFT (μm)

baseline

556.4 ± 117.2

538.9 ± 120.6

0.43

0.67

6 month

271.5 ± 51.4

235.2 ± 46.1

2.15

0.039

t

10.4418

8.8013

  

p

< 0.001

< 0.001

  

The retinal volume of the 6 mm-diameter macula (mm3)

baseline

11.32 ± 1.13

10.88 ± 1.11

1.15

0.26

6 month

8.91 ± 0.76

8.01 ± 0.70

3.57

0.001

t

8.3007

8.1831

  

p

< 0.001

< 0.001